http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0135271-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c902faf6ae746c51fc8010672fc22894 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-224 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-224 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-04 |
| filingDate | 1984-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e020fd549d9875a5a7a47572b498d31 |
| publicationDate | 1985-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0135271-A1 |
| titleOfInvention | Spectinomycin analogues and their preparation |
| abstract | Compounds of the formulan whereinn A is =0, α-H:β-OH or α-OH:β-H; R 1 is H or a blocking group; and R 3 is H, C 1.8 alkyl, C 1.4 mono-, di- or tri-haloalkyl, -R 31 -O-R 32 or -R 31 -NR 33 R 34 in which R 31 is C 1-4 alkylene, R 32 is H or C 1-6 alkyl, R 33 is H or C, a alkyl and R 34 is H, C 1-6 alkyl or a blocking group, provided that the number of carbon atoms in R 31 and R 32 , in R 31 and R 33 and in R 31 and R 34 (if R 34 is alkyl) is not more than 7; and pharmacologically acceptable salts thereof. n These sugar-ring expanded analogues of spectinomycin and its C-6' derivatives are prepared from 7-membered sugar-ring spectinomycin and spectinomycin derivatives, by treatment with sodium borohydride. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104725392-A |
| priorityDate | 1983-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 110.